Globus Medical, Inc.

NYSE:GMED

Medical - Devices

Healthcare
$70.53 -2.71%

-$2.10 today

Market cap
$9.34B
Beta
0.95
P/E (TTM)
17.4
EPS (TTM)
$4.33
52W Low $51.79High $101.40

Volume 1.43M

Average 1.45M

GMED Income Before Tax

Profit after all operating and non-operating items but before income tax.

Globus Medical, Inc.NYSE: GMED

Income Before Tax · Q2 FY2026 · quarter ended Jun 2026

Income before tax grows, but more slowly than its trailing trend

Q2 FY2026 income before tax of $189.82M rose 0.9% year over year, behind the +78.0% change in trailing-twelve-month income before tax. Sequentially, it rose 20.8% from the prior quarter. Over 3 fiscal years it compounded at +35.9% a year.

Context

  • Income before tax amounted to 20.8% of revenue in FY2025, up 16.0 pp from a year earlier.
  • Income before tax increased in 1 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +0.9% toward the trailing-twelve-month pace of +78.0%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
$189.82M+20.8% QoQ
Last fiscal yearDec 2025
$609.9M+405.2% YoY
LTMJun 2026
$664.95M+78.0% YoY
Income Before Tax past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+0.9%——
1 year+405.2%——
3-year CAGR+35.9%——
5-year CAGR——
10-year CAGR——

Income Before Tax history

USD · from the income statement

Latest · FY2025
609.9M USD
Year-over-year change
+405.2%
4-year CAGR
+35.6%

Income Before Tax vs competitors

How GMED compares with its peers on the latest reported figures

  • GMED's LTM Jun 2026 income before tax of $664.95M is the 4th highest of the 10 companies compared; the peer median is $3.91M.
  • Its year-over-year change of +78.0% is the 3rd highest of 10, against a peer median of +53.6%.
  • Income before tax amounts to 21.1% of revenue for GMED, versus a peer median of 11.0%.
GMED Competitors Peer median
Income Before Tax for GMED and competitors
Company Period LTM YoY 3-year CAGR% of revenue
SYKStryker CorporationLTM Jun 2026$5.15B +53.6%+18.9%19.9%
ZBHZimmer Biomet Holdings, Inc.LTM Jun 2026$933.6M -4.0%+27.2%11.0%
SNNSmith & Nephew plcFY2025$779M +56.4%+49.1%12.6%
GMEDGlobus Medical, Inc.LTM Jun 2026$664.95M +78.0%+35.9%21.1%
BVSBioventus Inc.LTM Mar 2026$33.64M +167.9%—5.8%
XTNTXtant Medical Holdings, Inc.LTM Mar 2026$3.91M +132.8%—3.2%
SIBNSI-BONE, Inc.LTM Mar 2026-$16.7M +37.1%—8.1%
KIDSOrthoPediatrics Corp.LTM Mar 2026-$39.58M +5.9%—16.3%
OFIXOrthofix Medical Inc.LTM Mar 2026-$59.51M +57.7%—7.2%
ATECAlphatec Holdings, Inc.LTM Mar 2026-$125.29M +24.3%—15.9%
Peer median (excluding GMED) $3.91M+53.6%+27.2%11.0%

Competitors are the stored peer set for GMED. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue958.1M1.02B1.57B2.52B2.94B
Cost of Revenue239.22M263.73M548.17M1.04B957.8M
Gross Profit718.88M759.12M1.02B1.48B1.98B
Gross Margin75.0%74.2%65.1%58.9%67.4%
Research & Development97.35M73.02M124.01M163.75M185M
Selling, General & Admin408.15M432.12M643.41M981.05M1.32B
Operating Expenses546.93M531.17M887.16M1.32B1.5B
Depreciation & Amortization69.87M68.25M144.73M254.02M276.84M
EBITDA264.73M304.5M346.58M473.73M886.74M
EBITDA Margin27.6%29.8%22.1%18.8%30.2%
Operating Income171.95M227.95M133.14M165.99M479.8M
Operating Margin17.9%22.3%8.5%6.6%16.3%
Interest Income9.3M14.23M20.13M07.14M
Interest Expense0004.19M0
Other Income / Expenses8.45M15.07M32.25M(45.27M)130.1M
Income Before Tax180.41M243.02M165.39M120.72M609.9M
Pre-Tax Margin18.8%23.8%10.5%4.8%20.8%
Income Tax Expense31.22M52.85M42.52M17.74M72M
Net Income149.19M190.17M122.87M102.98M537.9M
Net Margin15.6%18.6%7.8%4.1%18.3%
EPS (Basic)1.481.891.090.763.98
EPS (Diluted)1.441.851.070.753.92
Weighted Avg Shares100.73M100.47M113.09M135.73M135.15M
Weighted Avg Shares (Diluted)103.62M102.64M114.63M137.86M137.22M

Globus Medical, Inc.

NYSE:GMED

Intrinsic Alpha fair value

Locked

Current Price

$70.53

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.